225P Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M)
Autor: | Tanizaki, J., Yonemori, K., Takiguchi, Y., Akiyoshi, K., Komine, K., Onozawa, Y., Sato, M., Hirata, K., Onoe, T., Ishiguro, T., Ito, A., Chiba, Y., Watanabe, H., Togashi, Y., Sakai, K., Nishio, K., Nakagawa, K., Hayashi, H. |
---|---|
Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S305-S306 |
Databáze: | ScienceDirect |
Externí odkaz: |